Online Only Articles

DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype

Department of Haematology, Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK;Department of Haematology, Addenbrooke’s Hospital, Cambridge, UK;Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK
Department of Haematology, Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK
Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK
Department of Haematology, Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK;Department of Haematology, Addenbrooke’s Hospital, Cambridge, UK
Department of Haematology, Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK;Department of Haematology, Addenbrooke’s Hospital, Cambridge, UK;Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK
Department of Haematology, Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK
Department of Haematology, Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK
Department of Haematology, Addenbrooke’s Hospital, Cambridge, UK;Cambridge Blood and Stem Cell Bank, University of Cambridge, UK
Department of Haematology, Addenbrooke’s Hospital, Cambridge, UK;Cambridge Blood and Stem Cell Bank, University of Cambridge, UK
Department of Haematology, Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK
Department of Haematology, Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK;Department of Haematology, Addenbrooke’s Hospital, Cambridge, UK;Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK
Department of Haematology, Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK;Department of Haematology, Addenbrooke’s Hospital, Cambridge, UK
Vol. 100 No. 11 (2015): November, 2015 https://doi.org/10.3324/haematol.2015.129510